The Mission Report

LD Micro Invitational

June 7-9, 2016

Luxe Hotel Sunset Boulevard (Los Angeles)


The three-day LD Micro Invitational in Bel Air, California, features company presentations from more than 200 select high-potential small-cap companies spanning multiple industries. Institutional and retail investors in attendance also have access to numerous networking opportunities and social events to learn more about these companies.


  Track 1 Track 2 Track 3 Track 4
7:30 Entia, Inc. (ERGO)      
8:00 S&W Seed Company (SANW)     Ocean Power Technologies (OPTT)
8:30 22nd Century Group, Inc. (XXII) Premier Holding Corp. (PRHL) Alimera Sciences, Inc. (ALIM) Reliq Health Technologies, Inc. (FLNTF)
9:00 Vuzix Corp. (VUZI), Inc. (SPRT) Midwest Energy Emissions Corp. (MEEC) VolitionRx Limited (VNRX)
9:30 Finjan Holdings, Inc. (FNJN) Newtech Business Services Corp. (NEWT) Inovio Pharmaceuticals, Inc. (INO)
10:00 Marathon Patent Group, Inc. (MARA) Akoustis Technologies, Inc. (AKTS) IEG Holdings Corp. (IEGH) Citius Pharmaceuticals, Inc. (CTXR)
10:30 SharpSpring, Inc. (SHSP) Cel-Sci Corp. (CVM) Xtant Medical Holdings, Inc. (XTNT) Be Active Holdings, Inc. (JALA)
11:00 Xplore Technologies Corp. (XPLR) First Choice Healthcare Solutions, Inc. (FCHS) Cancer Genetics, Inc. (CGIX)
11:30 LM Funding America (LMFAU) Pharma Bio-Serve, Inc. (PBSV) Where Food Comes From, Inc. (WFCF) Staffing 360 Solutions, Inc. (STAF)
12:00   CafePress, Inc. (PRSS)    
12:30 Biolase, Inc. (BIOL) CV Sciences, Inc. (CANV) FTE Networks, Inc. (FTNW) Delcath Systems, Inc. (DCTH)
1:00 Sysorex Global (SYRX)   Signal Genetics, Inc. (SGNL)  
1:30 Willdan Group, Inc. (WLDN) Resonant, Inc. (RESN) CAS Medical Systems, Inc. (CASM) Dataram Corp. (DRAM)
2:00 Ironclad Performance Wear Corp. (ICPW) Imprimis Pharmaceuticals, Inc. (IMMY) MyDx, Inc. (MYDX)
2:30 Liquidmetal Technologies, Inc. (LQMT)   OncBioMune Pharmaceuticals, Inc. (OBMP) Spherix, Inc. (SPEX)
3:00 Mitek Systems, Inc. (MITK) Content Checked Holdings, Inc. (CNCK) T-Rex Oil, Inc. (TRXO)  
3:30 ProFire Enegry, Inc. (PFIE) Avant Diagnostics, Inc. (AVDX)   Solis Tek, Inc. (SLTK)
4:00 Capital Art, Inc. (CAPA)   U.S. Nuclear Corp. (UCLE)  
4:30     Bion Environmental Technologies, Inc. (BNET) LRAD Corp. (LRAD)
5:00 Reed's Inc. (REED) GSV Capital Corp. (GSVC) QuantumSphere, Inc. (QSIM)  

7:30 am

Entia Biosciences (ERGO)

Entia Biosciences (OTC: ERGO) develops patented, pharmaceutical-grade organic compounds, including one known as ErgoD2. Entia believes that ErgoD2 improves iron homeostasis and mitigates iron-related disorders presenting in anemia, chronic kidney disease and select neurodegenerative diseases. Entia's goal is to clinically validate and commercialize ErgoD2 through the prescription medical food and OTC supplement channels. Entia also develops and markets health-related cosmeceuticals. For more information, visit the company's website at

8:00 am

S&W Seed (SANW)

S&W Seed (NASDAQ: SANW) is a global agricultural company that supplies a range of forage and specialty crop products that support the global demand for animal proteins and healthier consumer diets. The company is a global leader in alfalfa seed, with research and development, production and distribution capabilities. S&W sells its seed products in more than 25 countries around the globe and is utilizing its research and breeding expertise to develop and produce stevia, the all-natural, zero calorie sweetener for the food and beverage industry. For more information, visit the company's website at

Ocean Power Technologies (OPTT)

Ocean Power Technologies (NASDAQ: OPTT) is a New Jersey-based pioneer in ocean wave energy conversion. OPT's proprietary PowerBuoy® technology is based on a scalable and modular design which allows for flexibility in meeting customer power requirements. The company specializes in cost-effective and environmentally sound ocean wave-based power generation and energy storage technology. For more information, visit the company's website at

8:30 am

22nd Century Group (XXII)

22nd Century Group (NYSE: XXII) is a plant biotechnology company focused on the development of technology that permits the management of nicotine levels in tobacco plants through genetic engineering and plant breeding. The company currently owns or exclusively controls more than 185 issued patents and more than 54 pending patent applications around the world. Through the development of innovative smoking cessation products and modified risk tobacco products, XXII aims to reduce the harm caused by conventional cigarettes. For more information, visit the company's website at

Premier Holding (PRHL)

Premier Holding (OTC: PRHL) provides financial support and management expertise, which includes access to capital, financing, legal, insurance, mergers, acquisitions, joint ventures and management strategies. The company's mission is to acquire clean technology companies and/or green products and services that are accretive and that can be seamlessly integrated and utilize the overall economics of such products and services for the benefit of its customers. For more information, visit the company's website at

Alimera Sciences (ALIM)

Alimera Sciences (NASDAQ: ALIM) is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The company is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in our aging populations. Alimera's product and development portfolio are designed to treat early- and late-stage diseases. For more information, visit the company's website at

Reliq Health Technologies (FLNTF)

Reliq Health Technologies (OTC: FLNTF) is a Vancouver-based healthcare technology company that specializes in developing innovative, secure mobile software solutions for the $20 billion community care market. Reliq's iUGO Health technology platform is a comprehensive hardware and software solution that allows complex patients to receive high quality care in the home, improving health outcomes, enhancing quality of life for patients & families and reducing the cost of care delivery. For more information, visit the company's website at

9:00 am

Vuzix (VUZI)

Vuzix (NASDAQ: VUZI) supplies video eyewear and smart glasses products to the consumer, enterprise and entertainment markets. The company's products include personal display and wearable computing devices that offer users a portable high quality viewing experience, provide solutions for mobility, wearable displays and virtual and augmented reality. Vuzix holds 40 patents and 23 additional patents pending and numerous IP licenses in the Video Eyewear field. The company won CES awards for innovation in 2005 to 2016, as well as several wireless technology innovation awards, among others. For more information, visit the company's website at (SPRT) (NASDAQ: SPRT) provides cloud software and services to deliver next-generation technical support. The company helps leading brands in software, electronics, communications, retail, Internet of Things and other connected technology industries deepen their customer relationships. By using software and services, companies can deliver a better customer experience, leading to happier customers, greater brand loyalty and growing revenues. For more information, visit the company's website at

Midwest Energy Emissions (MEEC)

Midwest Energy Emissions (OTC: MEEC) delivers patented and proprietary solutions to the global coal-power industry to remove mercury from power plant emissions. The EPA requires that all U.S.-based coal- and oil-fired power plants, larger than 25 mega-watts, must remove roughly 90% of mercury from their emissions. Midwest Energy's patented technology and proprietary products have been shown to achieve mercury removal levels at significantly lower cost and less operational impact than currently used methods, while preserving the marketability of fly-ash for beneficial use. For more information, visit the company's website at

VolitionRx Limited (VNRX)

VolitionRx Limited (NYSE: VNRX) is a life sciences company focused on developing blood-based diagnostic tests for different types of cancer. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream – an indication that cancer is present. VolitionRx's goal is to make the tests as common and simple to use, for both patients and doctors, as existing diabetic and cholesterol blood tests. VolitionRx's research and development activities are currently centered in Belgium as the company focuses on bringing its diagnostic products to market first in Europe, then in the U.S., and ultimately, worldwide. For more information, visit the company's website at

9:30 am

Finjan Holdings (FNJN)

Finjan Holdings (NASDAQ: FNJN) is a technology company whose early innovations and products helped define the state-of-the-art for detecting and deflecting software intrusions and malicious code delivery, over Internet and private networks, to devices located at endpoint connections. Finjan has successfully licensed its patents to a number of industry players, demonstrated a strong commitment to pursuing unlicensed companies through litigation, resulting in more than $145 million in licensing revenues, to date. The company continues to invest in the security sector and intends to broaden its technology and intellectual property holdings through continued acquisition, investment, and strategic partnerships. For more information, visit the company's website at

Newtech Business Services (NEWT)

Newtech Business Services (NASDAQ: NEWT), Your Business Solutions CompanyTM, is an internally managed BDC, which along with its controlled portfolio companies, provides a wide range of business services and financial products under the Newtek® brand to the small- and medium-sized business ("SMB") market. Since 1999, Newtek has provided state-of-the-art, cost-efficient products and services and efficient business strategies to over 100,000 SMB accounts across all 50 states to help them grow their sales, control their expenses and reduce their risk. For more information, visit the company's website at

Inovio Pharmaceuticals (INO)

Inovio Pharmaceuticals (NASDAQ: INO) is a pharmaceutical company using immunotherapy to fight against cancer and infectious diseases. It is the only immunotherapy company that has reported generating T cells in vivo in high quantity that are fully functional and whose killing capacity correlates with relevant clinical outcomes with a favorable safety profile. The company is focused on advancing a growing preclinical and clinical stage product pipeline. For more information, visit the company's website at

10:00 am

Marathon Patent Group (MARA)

Marathon Patent Group (NASDAQ: MARA) is focused on the acquisition and monetization of patents. The company acquires patents and patent rights from various patent owners ranging from individual inventors to Fortune 500 companies. The company monetizes patents and patent rights by entering in to license discussions, and settlement and license agreements. As of the end of 2014 MARA owned 378 patents and patent rights, and 22 patent applications in various technologies and markets. For more information, visit the company's website at

Akoustis Technologies (AKTS)

Akoustis Technologies (OTC: AKTS) is a high-tech RF filter solutions company with unique, patent-pending Bulk ONE™ acoustic wave technology used to produce single-crystal bulk acoustic wave (BAW) filters for the mobile-wireless industry. This technology facilitates signal acquisition and accelerates band performance between the antenna and the back-end of mobile devices. The BAW filter market is rapidly expanding, driven by growth in 4G/LTE and the number of filters required per device. Akoustis' "fabless" business model is capital efficient, leveraging existing manufacturing infrastructure in the semiconductor industry. For more information, visit the company's website at

IEG Holdings (IEGH)

IEG Holdings (OTC: IEGH) provides online unsecured consumer loans under the brand name, "Mr. Amazing Loans," via its website, Offerings its services in 17 U.S. states, the company offers $5,000 loans over a term of five years at a 23.9% to 29.9% APR. IEG Holdings plans future expansion to 25 U.S. states during 2016. For more information, visit the company's website at

Citius Pharmaceuticals (CTXR)

Citius Pharmaceuticals (OTC: CTXR) is a specialty pharmaceutical company that develops and commercializes therapeutic products. The company's product portfolio includes: Suprenza ODT, a phentermine orally disintegrating tablet used for the treatment of obesity; and Hydrocortisone-Lidocaine Cream, in phase 2 of clinical trials for the treatment of hemorrhoids. Citius has a collaboration and license agreement with Alpex Pharma S.A. to develop and commercialize orally disintegrating tablet formulations of pharmaceutical products throughout North America. The company recently announced its acquisition of Leonard Meron, a late-stage specialty pharmaceutical company focused on the development and commercialization of critical care products with a concentration on anti-infective drugs. For more information, visit the company's website at

10:30 am

SharpSpring (SHSP)

SharpSpring (NASDAQ: SHSP) is a global provider of cloud-based marketing and email software solutions, ranging from marketing automation to scalable transactional email, email marketing, and mobile marketing services. SharpSpring's product lines are known for innovation, flexible architecture, ease of use, and cost-effectiveness. Previously known as SMTP, Inc., the company delivered scalable solutions for email delivery. The company grew organically and profitably and reached the NASDAQ 2014, secured a secondary offering to pursue strategic acquisitions, and acquired SharpSpring and GraphicMail. The company changed its name to SharpSpring in 2015. For more information, visit the company's website at


CEL-SCI (NYSE: CVM) is primarily focused on R&D to improve the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system. Its lead investigational therapy, Multikine, is currently being studied in a pivotal global phase 3 clinical trial, and is the first immunotherapeutic agent being developed as a potential first-line treatment for advanced primary head and neck cancer. CEL-SCI is also investigating an immunotherapy (LEAPS-H1N1-DC) as a possible treatment for H1N1 hospitalized patients and as a vaccine (CEL-2000) for rheumatoid arthritis (currently in preclinical testing) using its LEAPS technology platform. The investigational immunotherapy LEAPS-H1N1-DC treatment involves non-changing regions of H1N1 Pandemic Flu, Avian Flu (H5N1), and the Spanish Flu. For more information, visit the company's website at

Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical Holdings, Inc. (NYSE: XTNT) develops, manufactures and markets class-leading regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. With core competencies in both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets. For more information, visit the company's website at

Be Active Holdings (JALA)

Be Active Holdings (OTC: JALA) manufactures and markets all natural, probiotic-enriched Greek frozen yogurt under the Jala brand. The company's Greek frozen yogurt is packaged as low fat bars and pints, which are designed to appeal both the health conscious and weight conscious consumer. Be Active Holdings' founder and President Sam Pugliese was the previous founder and president of Skinny Cow ice cream brand, which was sold to Nestle for $76 million. For more information, visit the company's website at

11:00 am

Xplore Technologies (XPLR)

Xplore Technologies (NASDAQ: XPLR) is the No. 2 provider of a wide range of rugged Windows and Android tablet PCs worldwide. The company's award-winning tablet PCs are among the most durable and powerful in their class – able to withstand nearly any hazardous condition or environmental extreme. These devices are purposely built for the demanding workflow of the oil & gas, utilities, telecommunications, government, military, public safety, healthcare industries, and more. Xplore's products are sold and serviced across the Americas, Europe, Middle East, Africa, and Asia Pacific regions. For more information, visit the company's website at

First Choice Healthcare Solutions (FCHS)

First Choice Healthcare Solutions (OTC: FCHS) is focused on expanding its network of non- physician-owned medical centers, which concentrate on treating patients in the following specialties: orthopaedics, spine surgery, neurology, interventional pain management, and related diagnostic and ancillary services in key expansion markets throughout the Southeastern United States. Serving Florida's Space Coast, the company's flagship integrated platform currently administers over 100,000 patient visits each year and is comprised of First Choice Medical Group, The B.A.C.K. Center and Crane Creek Surgery Center. For more information, visit the company's website at

Cancer Genetics (CGIX)

Cancer Genetics (NASDAQ: CGIX) is a diagnostics company developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer. Its proprietary tests target cancers where prognosis information is critical and where predicting treatment outcomes using currently available techniques is limited. The company has commercially launched its first proprietary microarray diagnostic tests, and plans to provide the tests and services to oncologists and pathologists, cancer centers and physician offices, and to biopharmaceutical companies and clinical research organizations. For more information, visit the company's website at

11:30 am

LM Funding America (LMFAU)

LM Funding America (NASDAQ: LMFAU), together with its subsidiaries, is a specialty finance company that provides funding to nonprofit community associations primarily located in the state of Florida, as well as in the states of Washington and Colorado. The company offers funding to associations by purchasing a certain portion of the associations' rights to delinquent accounts that are selected by the associations arising from unpaid Association assessments. It is also involved in the business of purchasing delinquent accounts on various terms tailored to suit each Association's financial needs, including under its New Neighbor Guaranty™ program. The company was founded in 2008 and is based in Tampa, Florida. For more information, visit the company's website at

Pharma Bio-Serve (PBSV)

Pharma Bio-Serve (OTC: PBSV) is a compliance and technology transfer services consulting firm with a laboratory testing facility servicing the Puerto Rico, United States, Europe and Brazil markets. The company provides a broad range of compliance-related consulting services, including microbiological testing services and chemical testing services. Pharma Bio-Serve markets these services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, as well as allied products companies. The company's consulting team includes engineering and life science professionals, quality assurance managers and directors, and health sciences and engineering professionals. For more information, visit the company's website at

Where Food Comes From (WFCF)

Where Food Comes From (OTC: WFCF) is a third-party verification service for food production practices. The company supports more than 10,000 farmers, ranchers, processors, retailers, distributors and restaurants with a wide variety of value-added services through its IMI Global, International Certification Services, Validus Verification Services, and Sterling Solutions units. The company's Where Food Comes From® retail and restaurant labeling program utilizes the verification of product attributes to connect consumers to the sources of the food they purchase through product labeling and web-based information sharing and education. For more information, visit the company's website at

Staffing 360 Solutions (STAF)

Staffing 360 Solutions (NASDAQ: STAF) is engaged in the acquisition of domestic and international staffing organizations. Through this high growth buy-and-build model, the company has expanded from roughly $5 million in revenues in 2013 to over $145 million in revenues on a current annualized basis. The company's veteran management team is focused on converting its pipeline of acquisitions targets into M&A transactions that will fuel the company's growth past its publicly stated goal of achieving $300 million in revenue. For more information, visit the company's website at

12:00 pm

CafePress (PRSS)

CafePress (NASDAQ: PRSS) is an online gift shop with more than 1 billion items. CafePress customers can create their own designs or choose from designs already created by a global community of more than 2 million designers. CafePress was founded in 1999 and is the recognized pioneer of customizable products. The company is headquartered in Louisville, Kentucky, and has an additional office in Hayward, California. Its manufacturing facility, also located in Louisville, is the hub for fulfillment across the United States. Every CafePress product is printed in the USA. For more information, visit the company's website at

12:30 pm

Biolase (BIOL)

Biolase (NASDAQ: BIOL) is a medical device company that develops, manufactures, markets and sells laser systems for dentistry and medicine and also markets, sells and distributes dental imaging equipment. The company's proprietary laser products incorporate approximately 250 patented and 90 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its innovative products provide cutting-edge technology at competitive prices and are designed to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold approximately 31,200 laser systems to date in over 90 countries around the world. Laser products under development address the company's core dental market and other adjacent medical and consumer markets. For more information, visit the company's website at

CV Sciences (CANV)

CV Sciences (OTC: CANV) focuses on drug development activities on products containing the hemp plant extract cannabidiol (CBD) as the active pharmaceutical ingredient, and also is engaged in the sale of CBD, and the development, marketing and sale of end consumer products containing CBD, which is refined into its own PlusCBD Oil™ brand. CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by its medical and scientific advisory board, and state‐of‐the art production facilities. The company has achieved promising preclinical results in the development of cannabinoid medicines for treatment of a range of medical conditions. For more information, visit the company's website at

FTE Networks (FTNW)

FTE Networks (OTC: FTNW), together with its subsidiaries, provides international and regional telecommunications and technology systems, and infrastructure services. The company specializes in the design, engineering, installation and maintenance of various forms of telecommunications infrastructure, also provides wireless solutions to various wireless carriers, and designs, engineers, installs, repairs and maintains fiber optic, copper, and coaxial cable networks. FTE Networks serves Fortune 500 customers in the wireline and wireless telecommunications industry, as well as technology providers and integrators, cable television multiple system operators, and corporations, and state and local governments in the United States. For more information, visit the company's website at

Delcath Systems (DCTH)

Delcath Systems (NASDAQ: DCTH) is a specialty pharmaceutical and medical device company focused on oncology and the treatment of primary and metastatic liver cancers. The company's proprietary Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure. The company's second-generation system is currently marketed in Europe as a device as Delcath Hepatic CHEMOSAT® Delivery System for Melphalan (CHEMOSAT). In the U.S., the Melphalan/HDS system is considered a combination drug and device product, and is regulated as a drug by the U.S. Food and Drug Administration (FDA). Melphalan/HDS has not been approved for sale in the U.S. For more information, visit the company's website at

1:00 pm

Sysorex (SYRX)

Sysorex (NASDAQ: SYRX) develops systems and solutions that power the data-driven enterprise. The company blends virtual data from software and networks with the huge volume of physical data generated by mobile devices and Internet-connected things to open new worlds of insight. The company's solutions are designed to help organizations worldwide improve decision making, increase productivity, and fuel the discoveries of tomorrow. Headquartered in Palo Alto, California, the company has regional offices in North America, South America, Europe and the Middle East. For more information, visit the company's website at

Signal Genetics (SGNL)

Signal Genetics (NASDAQ: SGNL) is a commercial-stage molecular design company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company's lead product is its MyPRS® test, which is a microarray-based gene expression profile assay designed to test the presence of various groups of genes that predict low or high level risk of early relapse in patients suffering from multiple myeloma. For more information, visit the company's website at

1:30 pm

Willdan Group (WLDN)

Willdan Group (NASDAQ: WLDN) provides professional consulting and technical services to utilities, public agencies and private industry throughout the United States. The company's service offerings span a broad set of complementary disciplines that include energy efficiency and sustainability, engineering and planning, financial and economic consulting, and national preparedness. Willdan provides integrated technical solutions to extend the reach and resources of its clients, and provides all services through its subsidiaries specialized in each segment. For more information, visit the company's website at

Resonant (RESN)

Resonant (NASDAQ: RESN) is a late-stage development company creating innovative filter designs for radio frequency front-ends (RFFEs) for the mobile device industry. The RFFE is the circuitry in a mobile device responsible for analog signal processing. Filters are a critical component of the RF front-end that select the desired radio frequency signals and rejects unwanted signals. Using patented technology, Resonant has developed a new method of designing RF filters that can displace conventional filters by providing significant cost and size reductions, fewer components and improved performance. For more information, visit the company's website at

CAS Medical Systems (CASM)

CAS Medical Systems (NASDAQ: CASM) is a leader in non-invasive patient monitoring of cerebral oxygenation. The company's FORE-SIGHT Absolute Cerebral Oximeter provides a highly accurate, non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation for patients during critical care. Direct monitoring of tissue oxygenation alerts clinicians to otherwise unrecognized and dangerously low levels of oxygenation of the brain and other tissues, thereby allowing them to intervene appropriately in the care of their patients. In addition to FORE-SIGHT Oximeters and accessories, CAS Medical also provides proprietary non-invasive blood pressure monitoring solutions for OEM use. For more information, visit the company's website at

Dataram (DRAM)

Dataram (NASDAQ: DRAM) is an independent manufacturer of memory products and provider of performance solutions that increase the performance and extend the useful life of servers, workstation, desktops and laptops sold by leading manufacturers. Dataram's memory products and solutions are sold worldwide to OEMs, distributors, value-added resellers and end users. Seventy Fortune 100 companies are powered by Dataram. The company's mission is to deliver solutions that improve the performance of clients' computing environment, lower their total cost of ownership, and leverage their investment in technology. For more information, visit the company's website at

2:00 pm

Ironclad Performance Wear (ICPW)

Ironclad Performance Wear (OTC: ICPW) provides high-performance task-specific work gloves. The company created the performance work glove category in 1998, and continues to leverage its leadership position in the safety, construction and industrial markets through the design, development and distribution of specialized task-specific gloves for industries such as oil & gas extraction; automotive; and police, fire, first-responder and military. Ironclad engineers and manufactures its products with a focus on innovation, design, advanced material science and durability. Ironclad's gloves and apparel are available through industrial suppliers, hardware stores, home centers, lumber yards, and sporting goods retailers nationwide; and through authorized distributors in North America, Europe, Australia, Middle East and Asia. For more information, visit the company's website at

Imprimis Pharmaceuticals (IMMY)

Imprimis Pharmaceuticals (NASDAQ: IMMY) is a specialty pharmaceutical company focused on the development, production and dispensing of novel compounded pharmaceuticals. The company's two business programs, Imprimis Cares™ and Custom Compounding Choice™, focus on patient outcomes and affordability by offering high quality custom compounded drugs in all 50 states. Imprimis expects to use its proprietary drug delivery technology, coupled with licensed technologies, and proprietary formulations and market data, to identify pharmaceutical development opportunities where there is a significant unmet need for a new drug product. For more information, visit the company's website at


MyDx (OTC: MYDX) is a chemical detection and sensor technology company whose mission is to help people Trust & Verify™ what they put into their minds and bodies. The company's MyDx product is a patented, affordable portable analyzer that provides real-time chemical analysis and fits in the palm of consumers' hands. It owns a substantial and growing intellectual property portfolio of patents covering its technology. With its Canna sensor commercialized, it has four other sensors being developed in its lab that are compatible with the MyDx Analyzer and App. For more information, visit the company's website at

2:30 pm

Liquidmetal Technologies (LQMT)

Liquidmetal Technologies (OTC: LQMT) develops amorphous alloys that utilize the performance advantages offered by amorphous alloy technology. Amorphous alloys are unique materials that are distinguished by their ability to retain a random structure when they solidify, in contrast to the crystalline atomic structure that forms in ordinary metals and alloys. Liquidmetal Technologies is the first company to produce amorphous alloys in commercially viable bulk form, enabling significant improvements in products across a wide array of industries. For more information, visit the company's website at

OncBioMune Pharmaceuticals (OBMP)

OncBioMune Pharmaceuticals (OTC: OBMP) is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a proprietary vaccine technology that is designed to stimulate the immune system to attack its own cancer while not hurting the patient. The company's lead product, ProscaVax™ is scheduled to commence a phase 2 clinical study in early 2016. OncBioMune also has a portfolio of targeted therapies, some of which are biosimilars to blockbuster drugs. For more information, visit the company's website at

Spherix (SPEX)

Spherix (NASDAQ: SPEX) offers a diversified commercialization platform for protected technologies. The company draws on portfolios of pioneering technology patents to partner with and support product innovation. Through its recently announced acquisition of over a hundred patents from Rockstar Consortium and its previously announced acquisition of several hundred patents issued to Harris Corporation, Spherix intends to expand its activities in wireless communications and telecommunication sectors including antenna technology, Wi-Fi, base station functionality, and cellular to drive further value from its growing IP portfolio. For more information, visit the company's website at

3:00 pm

Mitek Systems (MITK)

Mitek Systems (NASDAQ: MITK) provides mobile capture and identity verification software solutions. The company's ID document verification allows an enterprise to verify a user's identity during a mobile transaction, enabling financial institutions, payments companies and other businesses operating in highly regulated markets to transact business safely while increasing revenue from the mobile channel. Mitek also reduces the friction in the mobile user experience with advanced data prefill. These innovative mobile solutions are embedded into the apps of more than 5,000 organizations and used by tens of millions of consumers daily for new account opening, insurance quoting, mobile check deposit and more. For more information, visit the company's website at

Content Checked Holdings (CNCK)

Content Checked Holdings (OTC: CNCK) has created a family of smartphone apps for people with dietary restrictions: ContentChecked, MigraineChecked and SugarChecked. ContentChecked and MigraineChecked are the first applications with comprehensive and accurate content information, and in-depth allergen and migraine definitions for over 70% of conventional U.S. food products. Each app gives consumers the ability to scan a product's bar code and determine if it is safe for consumption based on their allergy settings. The apps will recommend a suitable alternative if a product does contain one or more of a user's allergens. In support of this technology, Content Checked has created a robust database of allergens, migraine triggers and food ingredients that directly correlate with food allergies, intolerances, migraines and chronic headaches. For more information, visit the company's website at

T-Rex Oil (TRXO)

T-Rex Oil (OTC: TRXO) is an energy company focused on acquiring, exploring, developing and producing oil and natural gas properties predominately in the Rocky Mountains. The company's executives have extensive experience in managing oil and gas properties. T-Rex Oil has acquired producing wells and leases in Wyoming and Nebraska and is actively pursuing other expansion opportunities. The company's goal is to build steady, sustainable growth of its inventory of oil and gas properties. For more information, visit the company's website at

3:30 pm

ProFire Energy (PFIE)

ProFire Energy (NASDAQ: PFIE) provides combustion management and chemical injection solutions in the oil and gas industry. The company's products and services aid oil and natural gas producers in the safe and efficient transportation, refinement and production of oil and natural gas. Its combustion solutions and chemical injection systems closely monitor and control oilfield applications. ProFire technologies and solutions are remotely accessible to oilfield professionals allowing for monitoring and control of multiple sites and locations which increases safety and saves both time and money. For more information, visit the company's website at

Avant Diagnostics (AVDX)

Avant Diagnostics (OTC: AVDX) is a diagnostic company that focuses on the commercialization of a series of proprietary microarray-based diagnostic tests that provide early detection of cancers, neurodegenerative diseases, and other chronic and severe diseases. The company's premier product is OvaDx, a non-invasive proteomics diagnostic screening test for early detection of ovarian cancer. The company believes this test could be approved as the first pre-symptomatic screening test for ovarian cancer in the U.S., detecting all types and stages of ovarian cancer with high sensitivity and specificity. For more information, visit the company's website at

Solis Tek (SLTK)

Solis Tek (OTC: SLTK) imports, distributes and markets digital lighting equipment for the hydroponics industry, paying specific focus on the research, design, development and manufacturing of advanced, energy efficient indoor/greenhouse horticulture lighting and ancillary equipment. Using its proprietary technologies, Solis Tek provides innovative aptitudes with its ballast, reflector and lamp products. The company's vision is to apply the latest advances in high efficiency lighting and controls technology as well as effective manufacturing techniques to deliver highly differentiated products with clear benefits at competitive prices to the greenhouse and indoor horticulture markets. Solis Tek's customers include retail stores, distributors and commercial growers in the United States and abroad. For more information, visit the company's website at

4:00 pm

Capital Art (CAPA)

Capital Art (OTC: CAPA) offers one of the largest and most diverse collections of Vintage Hollywood imagery in the world. The collection spans the past 100 years of Hollywood, some of the world's most famous photographers and every major icon, movie and genre. The company's personalized global fundraising program is ideal for charities of all sizes and demographics. Each program considers the vision, mission and audience to present the most exclusive and unique signature images to raise funds for each cause. For more information, visit the company's website at

U.S. Nuclear (UCLE)

U.S. Nuclear (OTC: UCLE), through its subsidiaries, operates two leading nuclear radiation detection companies: Overhoff Technology Corp. and Optron Scientific Company Inc. The company designs, manufactures and markets branded, full line radiation detection and specialized advanced tritium technology for the nuclear energy industry and for emerging technological processes such as Thorium and Molten Salt (MSR) reactor technologies both domestically and internationally to customers such as United States Government Agencies, the U.S. military, homeland security, scientific laboratories, universities, hospitals, nuclear reactor facilities in the United States, China, Canada, South Korea, Argentina, Russia and others. For more information, visit the company's website at

4:30 pm

Bion Environmental Technologies (BNET)

Bion Environmental Technologies (OTC: BNET) has a patented technology platform that provides comprehensive and cost-effective treatment of livestock waste and recovers valuable assets from the waste stream, including renewable energy, nutrients and clean water. The company's technology is targeted toward water treatment and dairy/livestock production. Bion's treatment solutions have been accepted by EPA, USDA and other regulatory agencies. The company's core biological processes are protected by seven U.S. patents, with two pending, and six international patents, with applications pending in the EU, New Zealand, Mexico, Brazil, Argentina and Australia. For more information, visit the company's website at


LRAD (NASDAQ: LRAD) uses advanced technology and voice intelligibility for its proprietary Long Range Acoustic Devices® and revolutionary ONE VOICE® mass notification systems designed to safely hail and warn, inform and direct, prevent misunderstandings, determine intent, establish large safety zones, resolve uncertain situations, and save lives. LRAD systems are in service in more than 70 countries around the world in diverse applications including mass notification and public address, fixed and mobile defense deployments, homeland, border, critical infrastructure, maritime, oil & gas, and port security, public safety, law enforcement and emergency responder communications, asset protection, and wildlife control and preservation. For more information, visit the company's website at

5:00 pm

Reed's (REED)

Reed's (NYSE: REED) makes and sells top-selling natural sodas in the natural foods industry sold in over 15,000 natural food markets and supermarkets nationwide. It has six award-winning non-alcoholic Ginger Brews and owns the top-selling root beer line and a top-selling cola line in natural foods. In 2012, the company launched a line of organic live beverages. Reed's products are sold through specialty gourmet and natural food stores, mainstream supermarket chains, retail stores and restaurants nationwide and in Canada, as well as through major supermarket chains. For more information, visit the company's website at

GSV Capital (GSVC)

GSV Capital (NASDAQ: GSVC) is an investment fund that seeks to invest in high-growth, venture-backed private companies. The company is led by industry veteran Michael Moe to create a portfolio of high-growth emerging private companies via a repeatable and disciplined investment approach, as well as to provide investors with access to such companies through its publicly traded common stock. In addition to private marketplaces, GSVC buys secondary shares directly from employees and early VCs, as well as primary shares directly from the company. For more information, visit the company's website at

Quantum Sphere (QSIM)

Quantum Sphere (OTC: QSIM) produces high-performance nano-scale catalysts designed to improve process efficiencies and output in large-scale chemical production facilities, with the potential to deliver lower costs and greater profits for chemical producers. The company's products leverage patented processes to produce a unique high surface area catalyst accelerator technology, which improves existing commercial catalyst performance. QSI's technology is applicable to hundreds of chemical plants globally. For more information, visit the company's website at


For more frequent updates, follow us on Twitter!

Home     About Us     IR Services     Investors     Partners     Market Research     Blog     Contact     Disclaimer

© 2014 Mission Investor Relations. All rights reserved.
3645 Marketplace Blvd.   Suite 130-280   Atlanta, GA 30344   404-941-8975